S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
Clinical trial NCT00234039 · COMPLETED
Trial details
- NCT number
- NCT00234039
- Sponsor
- SWOG Cancer Research Network
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2011-11-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.